Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
基本信息
- 批准号:7922796
- 负责人:
- 金额:$ 10.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-29 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAgonistAmino Acid SequenceAnesthesia proceduresAnestheticsBreathingBronchodilationCellsChemosensitizationClinicalConsciousCoupledDevelopmentElectrodesElectrophysiology (science)ExhibitsFacultyGeneral AnesthesiaGeneral HospitalsGeneral anesthetic drugsHalothaneHypoxiaInbred F344 RatsIon ChannelIsofluraneKnowledgeLeadMammalian CellMediatingMemoryMethodsMolecularMolecular Biology TechniquesMuscarinicsMuscle TonusNervous system structureNeuraxisNeurosciencesPeripheralPharmaceutical PreparationsPharmacologyPotassiumPotassium ChannelPrincipal InvestigatorProgram DevelopmentProteinsPublic HealthRNA InterferenceReceptor ActivationReceptor InhibitionRegulationResearchResearch PersonnelResistanceRoleSignaling ProteinSiteSite-Directed MutagenesisSmooth MuscleTestingThyroid GlandTissuesTraining ProgramsVasodilationWakefulnessWorkXenopus oocytebasecell typeclinically relevantdepresseddesfluranemedical schoolsmembermutantnovelpatch clampprogramsreceptor couplingreceptor functionreconstitutionresponsesevofluraneskillsvoltage clamp
项目摘要
This proposal describes a 5-year training program for the development of an independent investigator in
volatile anesthetic mechanisms. The principal investigator is a faculty member in the Department of
Anesthesia, Harvard Medical School, with a background in electrophysiology,who will acquire new
knowledge and skills in neuroscience and pharmacology sufficient to lead his own independent research
program. Work will be conducted in the Mallinckrodt Pharmacology Research Unit at Massachussets
General Hospital which focuses on volatile anesthetic mechanisms. ;
Our SPECIFIC AIMS wil test the novel hypothesis that volatile anesthetics potentiate TASK-3 function
indirectly by inhibition of basal or agonst-mediated Galpha-q protein coupled receptor (GqPCR) activity. The
TASK-3 tandem pore potassium channel is a volatile anesthetic-potentiated and pH- and hypoxia-inhibited
ion channel. TASK-3 is widely expressed in the central nervous system and in peripheral tissue and has a
role in chemosensing in a variety of cell types, including those involved in regulation of breathing. TASK-3
function is also inhibited by GqPCR activation. GqPCRs in the CNS regulate memory, wakefulness, and
consciousness and peripherally are important regulators of smooth muscle tone. The function of many
GqPCRs are inhibited by volatile anesthetics. To test our hypothesis we will use two-electrode voltage
clamp of Xenopus oocytes or Ussing Chamber studies of Fischer Rat Thyroid cells heterologously
expressing TASK-3 channels and ml or m3 GqPCRs and Galpha-q protein. We will also employ the excised
patch-clamp method, and several molecular biology techniques including RNA interference and site-directed
mutagenesis. LONG TERM GOALS: This project will clairfy the molecular mechanism by which volatile
anesthetics potentiate TASK channels. RELEVANCE TO PUBLIC HEALTH: This work will help establish
principles to guide development of safer anesthetic drugs that do not effect breathing and further elucidate
the mechanism by which these drugs induce anesthesia. i
该提案描述了一个为期5年的培训计划,以培养一名独立的调查员,
挥发性麻醉机制首席研究员是一名教员在系
麻醉,哈佛医学院,在电生理学的背景,谁将获得新的
在神经科学和药理学方面的知识和技能足以领导他自己的独立研究
程序.工作将在马萨诸塞州的马林克罗特药理学研究室进行
重点研究挥发性麻醉机制的综合医院。;
我们的具体目标是检验挥发性麻醉剂增强任务-3功能的新假设
间接通过抑制基础或激动剂介导的Galpha-q蛋白偶联受体(GqPCR)活性。的
ASK-3串联孔钾通道是一种挥发性麻醉增强和pH和缺氧抑制的钾通道
离子通道ASK-3在中枢神经系统和外周组织中广泛表达,并具有与神经系统相关的功能。
在各种细胞类型中的化学传感中起作用,包括参与呼吸调节的细胞。任务-3
功能也受到GqPCR激活的抑制。CNS中的GqPCR调节记忆、觉醒和
意识和外周是平滑肌张力的重要调节器。多元函数
GqPCR被挥发性麻醉剂抑制。为了验证我们的假设,我们将使用双电极电压
爪蟾卵母细胞钳夹法或Ussing小室法研究Fischer大鼠甲状腺细胞的异源性
表达ASK-3通道和ml或m3 GqPCR和Galpha-q蛋白。我们也会雇佣那些
膜片钳方法以及RNA干扰和定点等多种分子生物学技术
诱变长期目标:该项目将阐明挥发性化合物的分子机制,
麻醉剂增强了任务通道。与公共卫生的关系:这项工作将有助于建立
指导开发不影响呼吸的更安全麻醉药物的原则,并进一步阐明
这些药物诱导麻醉的机制。我
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph F Cotten其他文献
Joseph F Cotten的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph F Cotten', 18)}}的其他基金
Anesthetic activation of TASK-3 tandem pore potassium channels: molecular mechanisms and behavioral effects
TASK-3串联孔钾通道的麻醉激活:分子机制和行为效应
- 批准号:
9900029 - 财政年份:2018
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
9264573 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
8843947 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
9058592 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
8478315 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
TASK Potassium Channel Antagonists to Treat Opioid Depression of Breathing
TASK 钾通道拮抗剂治疗阿片类药物呼吸抑制
- 批准号:
8665480 - 财政年份:2013
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
7530533 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
7681262 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
7924160 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
Volatile Anesthetic Regulation of TASK Tandem Pore Potassium Channels
TASK 串联孔钾通道的挥发性麻醉调节
- 批准号:
8320182 - 财政年份:2008
- 资助金额:
$ 10.8万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 10.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 10.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




